|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 412 1st Street, SE |
Address2 | Suite 3 |
City | Washington |
State | DC |
Zip Code | 20003 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400660986-24
|
||||||||
|
6. House ID# 414350000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: G. David Mason |
Date | 1/22/2021 8:15:30 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Legislation and policies related to:
Physician/nurse practitioner reimbursement
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015 (P.L. 114-10) including policies related to the Quality Payment Program
Adoption of recommendations of the Institute of Medicine report, The Future of Nursing: Leading Change, Advancing Health
Medicare Shared Savings Program beneficiary assignment requirements
Medicare-Medicaid hospital conditions of participation
Evaluation of the Medicare Graduate Nurse Education demonstration
Medicare-Medicaid Program Integrity policies
Medicaid maintenance of effort requirements
Medicaid eligibility expansion and state options
Medicaid waiver application procedures
Medicaid per capita cap policy options
Promoting Access to Diabetic Shoes Act (H.R. 808/S. 237)
ACO Assignment Improvement Act of 2019 (H.R. 900)
Medicare for All Act of 2019 (H.R. 1384)
Protecting Patients Transportation to Care Act (H.R. 3935/S. 2846)
Strengthening Innovation in Medicare and Medicaid Act (H.R. 5741)
Home Health Care Planning Improvement Act of 2019 (S. 296/H.R. 2150)
Childrens Health Insurance Program Pandemic Enhancement and Relief (CHIPPER) Act (S. 3881/H.R. 6797)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Legislation and policies relating to:
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Reauthorization of funding for the Childrens Health Insurance Program
Reauthorization of the Child Nutrition Act
Section 2706 of the ACA regarding provider non-discrimination
Policies related to health insurance market stabilization
Policies affecting nurse practitioner education and workforce
Definition, evaluation and enforcement of essential health benefits and provider network adequacy
Health information technology and electronic health records
Mental health services and violence prevention
Human and child trafficking
Palliative Care and Hospice Education and Training Act (H.R. 647/S. 2080)
Title VIII Nursing Workforce Reauthorization Act of 2019 (H.R. 728/S. 1399)
Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748/S.3548)
Emergency Medical Services for Children Program Reauthorization Act of 2019 (H.R. 776/S. 1173)
End Surprise Billing Act of 2019 (H.R. 861)
Fairness for Breastfeeding Mothers Act (H.R. 866/S. 528)
Heroes Act (H.R. 925)
Mental Health Access Improvement Act of 2019 (H.R. 945)
Mental Health Services for Students Act of 2019 (H.R. 1109)
Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 1309)
Competitive Health Insurance Reform Act of 2020 (H.R. 1418)
Patient Protection and Affordable Care Enhancement Act (H.R. 1425)
Healthy Families Act (H.R. 1784/S. 840)
Mothers and Offspring Mortality and Morbidity Awareness (MOMMAs) Act (H.R. 1897)
School-Based Health Centers Reauthorization Act of 2019 (H.R. 2075/S. 1013)
Scarlett's Sunshine on Sudden Unexpected Death Act (H.R. 2271/S. 1130)
Easy MAT for Opioid Addiction Act (H.R. 2281)
Community Health Investment, Modernization, and Excellence Act of 2019 (H.R. 2328)
Newborn Screening Saves Lives Reauthorization Act of 2019 (H.R. 2507)
Pregnant Workers Fairness Act (H.R. 2694)
Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act of 2019 (H.R. 2781)
Vaccine Awareness Campaign to Champion Immunization Nationally and Enhance Safety (VACCINES) Act of 2019 (H.R. 2862)
Physical Activities Recommendations for Americans Act of 2019 (H.R. 2891)
Safe Cribs Act of 2019 (H.R. 3170)
Safe Sleep for Babies Act of 2019 (H.R. 3172)
Pathways to Health Careers Act (H.R. 3398)
Chronic Care Management Improvement Act (H.R. 3436)
No Surprises Act (H.R. 3630)
Midwives for Maximizing Optimal Maternity Services (Midwives for MOMS) Act of 2019 (H.R. 3849)
Social Determinants Accelerator Act of 2019 (H.R. 4004/S. 2986)
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019 (H.R. 3328/H.R. 4100/S. 1712)
Effective Suicide Screening and Assessment in the Emergency Department Act of 2019 (H.R. 4861/S. 3006)
United States Public Health Service Modernization Act of 2019 (H.R. 4870/S. 2629)
Medication Access and Training Expansion (MATE) Act of 2019 (H.R. 4974)
Maternal Health Quality Improvement Act of 2019 (H.R. 4995)
Helping Medicaid Offer Maternity Services (MOMS) Act of 2019 (H.R. 4996)
Protecting Seniors Through Immunization Act of 2019 (H.R. 5076/S. 1872)
Pursuing Equity in Mental Health Act of 2019 (H.R. 5469)
Primary and Behavioral Health Care Access Act (H.R. 5575)
Ban Surprise Billing Act (H.R. 5800)
Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826)
Black Maternal Health Momnibus Act of 2020 (H.R. 6142/S. 3424)
Families First Coronavirus Response Act (H.R. 6201)
Take Responsibility for Workers and Families Act (H.R. 6379)
Health Care at Home Act (H.R. 6644)
COVID-19 Mental Health Research Act (H.R. 6645)
HEROES Act (H.R. 6800)
Child Care Is Essential Act (H.R. 7027)
Ensuring Children and Child Care Workers Are Safe Act of 2020 (H.R. 7079)
Child Care for Economic Recovery Act (H.R. 7327)
Protect Telehealth Access Act (H.R. 7391)
Protecting Access to Post-COVID-19 Telehealth Act of 2020 (H.R. 7663)
Community and Public Health Programs Extension Act (S. 192)
National Nurse Act of 2019 (S. 696/H.R. 1597)
Excellence in Mental Health and Addiction Treatment Expansion Act (S. 824/H.R. 1767)
Nursing Where It's Needed Act (S. 1045)
Promoting Physical Activity for Americans Act (S. 1608)
Lower Health Care Costs Act (S. 1895)
National Suicide Hotline Designation Act (S. 2661)
Child Care Protection Improvement Act of 2019 (S. 2683)
CONNECT for Health Act of 2019(S. 2741/H.R. 4932)
CAPTA Reauthorization Act of 2019 (S. 2971)
Suicide Prevention Act (S. 3198/H.R. 5619)
Eliminating Abusive and Rampant Neglect of Interactive Technologies (EARN IT) Act of 2020 (S. 3398)
Tele-Mental Health Improvement Act (S. 3792)
Coronavirus Mental Health and Addiction Assistance Act of 2020 (S. 3825/H.R. 6999)
Mental and Behavioral Health Connectivity Act (S. 3999)
Future Advancement of Academic Nursing (FAAN) Act (S. 4396/H.R. 7945)
Safe Authorization for Vaccines during Emergencies (SAVE) Act (S. 4427)
Pioneering Antimicrobial Subscriptions to End Up surging Resistance (PASTEUR) Act of 2020 (S. 4760)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Legislation and policies relating to:
Authorization and appropriations of Title VIII funding for nurse education and nurse workforce development programs in fiscal years 2020 and 2021
FY 2020 and 2021 appropriations for antimicrobial research programs
FY 2020 and 2021 appropriations for the Childrens Hospitals Graduate Medical Education Program
FY 2020 and 2021 appropriations for the FDA Pediatric Device Consortia Grant Program
Consolidated Appropriations Act, 2021 (H.R. 133)
Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (H.R. 2740)
Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019 (H.R. 3055)
Bipartisan Budget Act of 2019 (H.R. 3877)
Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 (H.R. 4378)
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R.6074)
State, Foreign Operations, Agriculture, Rural Development, Interior, Environment, Military Construction, and Veterans Affairs Appropriations Act, 2021 (H.R. 7608)
Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 (H.R. 7617)
Continuing Appropriations Act and Other Extensions Act (H.R. 8337)
Bipartisan Congressional Budget Reform Act (S. 2765)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Legislation and policies related to:
Pediatric and childrens health research
Nursing research
Gun Violence Prevention Research Act (S. 184/H.R. 674)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Legislation and policies related to:
Tax policies related to health care coverage, subsidies and exemptions
Personal Health Investment Today (PHIT) Act (S. 680/H.R. 1679)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Legislation and policies related to:
Immigration, visa status, and deportation of children and families with children, including the Deferred Action for Childhood Arrivals program
Dream and Promise Act (H.R. 6)
No Federal Funds for Public Charge Act of 2019 (H.R. 3222/S. 2483)
Humanitarian Standards for Individuals in Customs and Border Protection Custody Act (H.R. 3239)
U.S. Border Patrol Medical Screening Standards Act (H.R. 3525)
Protect American Values Act (S. 2482)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Homeland Security - Dept of (DHS), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Legislation and policies related to:
Accreditation and curriculum of advance practice nursing education programs
Policies and requirements related to scholarship and loan repayment programs for advanced practice registered nurses
Pathways to Health Careers Act (H.R. 3398)
College Affordability Act (H.R. 4674)
Protecting JOBs Act (S. 609/H.R. 3689)
Future Advancement of Academic Nursing (FAAN) Act (S. 4396/H.R. 7945)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Education - Dept of, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
Legislation and policies related to:
Firearms and gun violence protections for children, families, and health care providers, including schools and health care facilities
Bipartisan Background Checks Act of 2019 (H.R. 8)
Raise the Age Act (H.R. 717)
Keep Americans Safe Act (H.R. 1186)
Background Check Expansion Act (S. 42)
Assault Weapons Ban Act of 2019 (S. 66)
Gun Violence Prevention Research Act (S. 184/H.R. 674)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Bureau of Alcohol Tobacco Firearms & Explosives
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Legislation and policies related to:
Environmental protections affecting the health and safety of children, families, and health care providers
A resolution recognizing the duty of the Federal Government to create a Green New Deal (H. Res. 109/S. Res. 59)
Recognizing the duty of the Federal Government to create a Green New Deal (S.J. Res. 8)
Clean Economy and Jobs Innovation Act (H.R. 4447)
Advanced Geothermal Innovation Leadership Act of 2019 (S. 2657)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Legislation and policies related to:
Promotion of cessation of tobacco use and smoking, including e-cigarettes and vaping devices
Preventing child and youth access to and use of tobacco products including e-cigarettes and vaping devices
Stopping Consumption of Tobacco by Teens (SCOTT) Act of 2019 (H.R. 2084)
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339)
Preventing Online Sales of E-Cigarettes to Children Act (H.R. 3942/S. 1253)
Quell Underage Inhaling of Toxic Substances (QUITS) Act of 2019 (H.R. 4425)
Protecting American Lungs Act (H.R. 4742)
Quit Because of COVID-19 Act (H.R 7286/S. 4524)
E-Cigarette Youth Protection Act (S. 616)
Stopping Appealing Flavors in E-Cigarettes for Kids (SAFE Kids) Act (S. 655/H.R. 1498)
Tobacco to 21 Act (S. 1258/H.R. 2411)
Tobacco-Free Youth Act (S. 1541)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Legislation and policies related to:
Revision and implementation of Department of Veterans Affairs regulation RIN 2900-AP44, Advanced Practice Registered Nurses
United States Cadet Nurse Corps Service Recognition Act of 2019 (S. 997/H.R. 2056)
National Defense Authorization Act for Fiscal Year 2021 (S. 4049)
William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 (H.R. 6395)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Legislation and policies related to:
APRN prescribing authority
Development, testing and prescribing of pediatric pharmaceuticals
Lower Drug Costs Now Act of 2019 (H.R. 3)
Prescription Drug Pricing Reduction Act of 2019 (S. 2543)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Legislation and policies related to:
Programs and grants to encourage greater youth physical fitness and activity, and to combat obesity
Moving Forward Act (H.R. 2)
Small Airport Mothers Rooms Act of 2019 (H.R. 3362)
Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act (H.R. 7095)
Americas Transportation Infrastructure Act of 2019 (S. 2302)
Travelling Parents Screening Consistency Act of 2019 (S. 2381)
Friendly Airports for Mothers Act (S. 2638)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Legislation and policies related to:
Financial assistance for nurse practitioners and their practices
Financial assistance for 501(c)(6) nonprofit professional associations
Paycheck Protection Program and Health Care Enhancement Act (H.R. 266)
Paycheck Protection Program Flexibility Act of 2020 (H.R. 7010)
An act to extend the authority for commitments for the Paycheck Protection Program (S. 4116)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Treasury - Dept of, Vice President of the U.S., White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |